Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Analysis of the mRNA expression of chemotherapy-related genes in colorectal carcinoma using the danenberg tumor profile method.

Sasaki S, Watanabe T, Nakayama H.

J Oncol. 2013;2013:386906. doi: 10.1155/2013/386906. Epub 2013 Mar 16.

2.

Relationship between the expression of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase and survival in epithelial ovarian cancer.

Wang C, Weng Y, Wang H, Shi Y, Ma D.

J Huazhong Univ Sci Technolog Med Sci. 2010 Aug;30(4):494-9. doi: 10.1007/s11596-010-0456-y. Epub 2010 Aug 17.

PMID:
20714877
3.

A retrospective study on TS mRNA expression and prediction of the effects of adjuvant oral 5-fluorouracil in breast cancer.

Aki F, Bando Y, Takahashi T, Uehara H, Numoto S, Ito S, Sasa M, Izumi K.

Oncol Lett. 2010 Nov;1(6):981-987. Epub 2010 Sep 23.

4.

Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis.

Inokuchi M, Uetake H, Shirota Y, Yamada H, Tajima M, Sugihara K.

Cancer Chemother Pharmacol. 2004 May;53(5):391-6. Epub 2004 Jan 20.

PMID:
15060742
5.

Low thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase mRNA expression correlate with prolonged survival in resected non-small-cell lung cancer.

Grimminger PP, Schneider PM, Metzger R, Vallböhmer D, Hölscher AH, Danenberg PV, Brabender J.

Clin Lung Cancer. 2010 Sep 1;11(5):328-34. doi: 10.3816/CLC.2010.n.041.

PMID:
20837458
7.

Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.

Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C.

Oncology. 2006;70(5):366-77. Epub 2006 Dec 15.

PMID:
17179731
8.

Prognostic value of biomarkers in metastatic colorectal cancer patients.

Kataoka K, Kanazawa A, Nakajima A, Yamaguchi A, Arimoto A.

J Surg Res. 2015 Apr;194(2):343-50. doi: 10.1016/j.jss.2014.10.006. Epub 2014 Oct 13.

PMID:
25456112
9.

Thymidine phosphorylase and dihydropyrimidine dehydrogenase activity in colorectal carcinoma and patients prognosis.

Ikeguchi M, Makino M, Kaibara N.

Langenbecks Arch Surg. 2002 Oct;387(5-6):240-5. Epub 2002 Sep 18.

PMID:
12410361
10.

Significance of dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expressions in hepatocellular carcinoma.

Nii A, Shimada M, Ikegami T, Harino Y, Imura S, Morine Y, Kanemura H, Arakawa Y, Sugimoto K.

Hepatol Res. 2009 Mar;39(3):274-81. doi: 10.1111/j.1872-034X.2008.00457.x. Epub 2008 Nov 25.

PMID:
19054147
11.

Possibility of using mRNA expression levels for nucleic acid-metabolizing enzymes within prostate cancer cells as indices for prognostic factors.

Yano A, Shigematsu Y, Kitano H, Hanayama A, Ozawa A, Tacho T, Fujii M.

Oncol Lett. 2010 Nov;1(6):1049-1053. Epub 2010 Sep 1.

13.

Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.

Kinoshita M, Kodera Y, Hibi K, Nakayama G, Inoue T, Ohashi N, Ito Y, Koike M, Fujiwara M, Nakao A.

Anticancer Res. 2007 Mar-Apr;27(2):851-6.

14.

Expression level of thymidylate synthase mRNA reflects 5-fluorouracil sensitivity with low dose and long duration in primary colorectal cancer.

Okumura K, Mekata E, Shiomi H, Naitoh H, Abe H, Endo Y, Kurumi Y, Tani T.

Cancer Chemother Pharmacol. 2008 Apr;61(4):587-94. Epub 2007 May 23.

PMID:
17520254
15.
16.

5-fluorouracil-related gene expression levels in primary colorectal cancer and corresponding liver metastasis.

Kuramochi H, Hayashi K, Uchida K, Miyakura S, Shimizu D, Vallbohmer D, Park S, Danenberg KD, Takasaki K, Danenberg PV.

Int J Cancer. 2006 Aug 1;119(3):522-6.

17.

Messenger RNA expression of TS and ERCC1 in colorectal cancer and matched liver metastasis.

Kobayashi H, Sugihara K, Uetake H, Higuchi T, Yasuno M, Enomoto M, Iida S, Azuma M, Mori R, Omori A, Lenz HJ, Danenberg KD, Danenberg PV.

Int J Oncol. 2008 Dec;33(6):1257-62.

PMID:
19020759
18.

Clinical significance of the gene expression profile in residual tumor cells after neoadjuvant chemo-radiotherapy for esophageal cancer.

Tanaka K, Otake K, Mohri Y, Ohi M, Yokoe T, Toiyama Y, Miki C, Tonouchi H, Kusunoki M.

Oncol Rep. 2009 Jun;21(6):1489-94.

PMID:
19424628
20.

Analysis of 5-fluorouracil-related enzymes in pulmonary neuroendocrine carcinoma: differences in biological properties compared to epithelial carcinoma.

Nagasaki T, Tsuchiya T, Tagawa T, Honda S, Yamasaki N, Miyazaki T, Hidaka S, Hayashi T, Nagayasu T.

Clin Lung Cancer. 2010 Nov 1;11(6):412-22. doi: 10.3816/CLC.2010.n.053.

PMID:
21062732

Supplemental Content

Support Center